
    
      Subjects will participate in four phases of the study: Baseline of 50 days and three
      intervention phases which include 50 days receiving product followed by 50 days of recovery.
      The total duration of the study will be 350 days. If participant has not been previously
      labeled with 41Ca, a 150 day period is added to the study.

      Hesperidin (552mg) and Calcilock® (amount per day: Calcium: 684 mg; Phosphorus: 282mg;
      Magnesium: 102mg; Zinc: 2.86mg; Vitamin C: 20 mg; Vitamin K1: 28µg; Vitamin D: 1.86µg) will
      be administered in the form of cookies (biscuit).
    
  